Metagenomi, Inc. Common Stock (MGX) NASDAQ

2.71

+0.155(+6.08%)

Updated at February 05 11:47AM

Currency In USD

Valuation

Market Cap386.91M
Enterprise Value294.54M
P/E Ratio-1.34
PEG Ratio-1.69
Price/Sales Ratio1.84
Price/Book Ratio0.39
Enterprise/Revenue2.22
Enterprise/EBITDA-1.53

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-1.34
Operating Margin-1.61

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.44

Income Statement

Revenue44.76M
Revenue/Share1.5
Gross Profit-49.65M
EBITDA-56.02M
Net Income-68.26M
Diluted EPS-1.82

Balance Sheet

Total Cash274.59M
Total Cash/Share7.47
Total Debt46.07M
Total Debt/Equity0.18
Current Ratio6.18
Book Value Per Share6.96

Price History

52-Week Change-73.76
52-Week High12.74
52-Week Low1.61
Moving Average 50 Days2.93
Moving Average 200 Days3.78

Statistics

Average Volume2.48M
Shares Outstanding37.42M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A